Qualigen Therapeutics Inc (QLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | QLGN | PCSA | CANF | ||
| Company | Qualigen Therapeutics Inc | Processa Pharmaceuticals Inc | Can-Fite Biopharma Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 2.98 | 2.30 | 3.27 | ||
| High | 3.34 | 2.63 | 3.27 | ||
| Low | 2.86 | 2.30 | 3.22 | ||
| Latest | 3.21 | 2.59 | 3.25 | ||
| Change | +0.17 | +0.35 | -0.04 | ||
| % Change | +5.59% | +15.63% | -1.22% | ||
| Volume | 373,800 | 29,602 | 4,544 | ||
| 20-Day Average Volume | 3,514,640 | 37,239 | 2,050,819 | ||
| Previous Close | 3.04 | 2.24 | 3.29 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.87 | 2.66 | 3.89 | ||
| 20-Day Raw Stochastic | 23.75% | 23.58% | 2.19% | ||
| 20-Day Relative Strength | 50.58 | 43.55 | 39.23 | ||
| Weighted Alpha | -59.50 | -71.46 | -86.98 | ||
| Today's Opinion | 24% Sell | 80% Sell | 100% Sell | ||
| Previous Opinion | 24% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 24% Buy | 100% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +22.52% since 11/11/25 | +1.72% since 03/20/26 | +3.15% since 03/20/26 | ||
| Low | 2.36 on 11/13/25 | 2.15 on 03/24/26 | 3.11 on 03/24/26 | ||
| High | 3.34 on 11/18/25 | 2.45 on 03/25/26 | 3.39 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -11.81% since 10/17/25 | +8.76% since 02/27/26 | -31.16% since 02/27/26 | ||
| Low | 2.35 on 11/07/25 | 2.07 on 03/02/26 | 3.11 on 03/24/26 | ||
| High | 5.97 on 10/24/25 | 3.30 on 03/16/26 | 10.40 on 03/04/26 | ||
| 3-Month | |||||
| %Chg | +68.95% since 08/18/25 | -39.80% since 12/26/25 | -23.56% since 12/26/25 | ||
| Low | 1.66 on 09/04/25 | 1.76 on 02/23/26 | 3.11 on 03/24/26 | ||
| High | 8.81 on 09/22/25 | 3.92 on 12/29/25 | 10.40 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | -17.05% since 05/16/25 | -55.68% since 09/26/25 | -73.84% since 09/26/25 | ||
| Low | 1.61 on 08/13/25 | 1.76 on 02/23/26 | 3.11 on 03/24/26 | ||
| High | 8.81 on 09/22/25 | 14.24 on 10/08/25 | 12.80 on 09/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,442 | 5,958 | 4,307 | ||
| Shares Outstanding, K | 1,695 | 2,660 | 1,309 | ||
| Annual Sales | 0 | 0 | 670,000 | ||
| Annual Net Income | -6,260,000 | -13,560,000 | -7,880,000 | ||
| Last Quarter Sales | 0 | 0 | 160,000 | ||
| Last Quarter Net Income | -2,040,000 | -3,360,000 | -1,650,000 | ||
| 60-Month Beta | 0.24 | 1.05 | 1.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -4.68 on 11/14/25 | -1.75 on 11/06/25 | N/A | ||
| Latest Earnings Date | 06/29/26 | 05/14/26 | 04/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||